The Engelberg Center for Health Care Reform at Brookings hosted the Fourth Annual Sentinel Initiative Public Workshop on Wednesday, January 18, at the Washington Marriott in Washington, DC. This public workshop brought together the stakeholder community for a productive discussion on a variety of topics in active medical product surveillance, including an update on the U.S. Food and Drug Administration’s (FDA’s) Sentinel Initiative; efforts to support the advancement of safety science; and stakeholder perspectives on the Sentinel Initiative’s progress and future direction.
Dr. Stephen Spielberg, the FDA’s newly appointed Deputy Commissioner for Medical Products and Tobacco, provided the morning keynote address.
Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute
Deputy Director for Clinical Science, Center for Drug Evaluation and Research - U.S. Food and Drug Administration
Consumer Reports Health Ratings Center
Chief Executive Officer - National Health Council
U.S. Food and Drug Administration
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.